Kiromic BioPharma, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -0.0846 | -100% |
| P/S |
|
0 | 33.76 | -100% |
|
|
| P/BV |
|
-0.0626 | 4.82 | -101.3% |
|
|
| P/FCF |
|
-0.1446 | 60.98 | -100.24% |
|
|
| Ev/Ebitda |
|
-0.6474 | -22.12 | -97.07% |
|
|
| Ev/S |
|
0 | 22.56 | -100% |
|
|
| Ev/FCF |
|
-0.6023 | 68.75 | -100.88% |
|
|
| E/P |
|
-6.76 | 0.0178 | -38133.76% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.83 | -100% | 0 | 0% |
| ROE |
|
229.69 | 9.61 | 2291.04% |
|
|
| ROA |
|
-172.15 | 0.3359 | -51350.43% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
0 | -25.17 | -100% |
|
|
| ROCE |
|
2364.67 | 15.33 | 15323.91% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.7795 | -3.67 | -78.74% | -0.3993 | 95.24% |
| Nеt Debt/Ebitda |
|
-0.6188 | -3.44 | -82.01% |
|
|
| Debt/Ratio |
|
1.28 | 0.1972 | 547.84% |
|
|
| Debt/Equity |
|
9.14 | 1.65 | 455.3% |
|
|
| Debt/Net Income |
|
-0.7419 | 10.31 | -107.2% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5496 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.1053 | -100% |
|
|
| DSI |
|
0 | 0.2174 | -100% |
|
|
| Average dividend growth |
|
0 | 0.0654 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5496 |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
0/10
|
0 | -56.89 | -100% |
| Growth impulse Ebitda 5 years |
|
373.85 | -64.81 | -676.84% |
| Growth impulse Net Income 5 years |
|
467.78 | -58.33 | -901.95% |
| Growth impulse FCF 5 years |
|
566.29 | -47 | -1304.87% |
| Growth impulse EPS 5 years |
|
-33.1 | -32.41 | 2.13% |
IP Score
3.89/10
